Simplify Asset Management »

X4 Pharmaceuticals shares owned by Simplify Asset Management

Quarter-by-quarter ownership of X4 Pharmaceuticals (XFOR) shares owned by Simplify Asset Management from 13F filings

Historical chart of Simplify Asset Management investment in X4 Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including X4 Pharmaceuticals held by Simplify Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in X4 Pharmaceuticals by Simplify Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $335k 400k 0.84
2023-09-30 $436k 400k 1.09
2023-06-30 $776k 400k 1.94
2023-03-31 $348k 400k 0.87

More positions owned by Simplify Asset Management

Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT)
Ishares Tr Core S&p500 Etf (IVV)
Simplify Exchange Traded Fun Aggregate Bond E (AGGH)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Simplify Exchange Traded Fun Stable Incm Etf (BUCK)
Plains Gp Hldgs Ltd Partnr Int A (PAGP)
Pimco Etf Tr 15+ Yr Us Tips (LTPZ)
Tesla Motors Call Option (TSLA)
Applied Therapeutics (APLT)
Ishares Tr Core Us Aggbd Et (AGG)
Simplify Exchange Traded Fun Short Term Trea (TUA)
Ishares Tr Mbs Etf (MBB)
Tscan Therapeutics (TCRX)
Simplify Exchange Traded Fun High Yield Plus (CDX)

View all positions for Simplify Asset Management

Top funds holding X4 Pharmaceuticals

NEA Management Company
Vanguard Group
OrbiMed Advisors
Perceptive Advisors
Kingdon Capital Management
Citadel Advisors
Millennium Management
GSA Capital Partners
Point72 Asset Management
Schonfeld Strategic Advisors
Propel Bio Management
Barclays
Simplify Asset Management
Royce & Associates
Bank of New York Mellon

View all funds holding X4 Pharmaceuticals